Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
133
天
An Early Value Assessment of Biomarker-Guided Precision Medicine for Treatment-Resistant Hypertension: A Headroom and Threshold Analysis
作者
Teebah Abu-Zahra; Sabine Grimm; Mirre Scholte; Ana I. Casas; Peter Saliba-Gustafsson; Paolo Parini; Manuela Joore展开收起
作者单位
1. Department of Clinical Epidemiology & Medical Technology Assessment (KEMTA), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands; 2. Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; 3. Departments of Medical Imaging and IQ health, Radboudumc, Nijmegen, The Netherlands; 4. Department of Neurology and Center for Translational Neuro- and Behavioural Sciences (C-TNBS), Clinic for Neurology, University Hospital Essen, Essen, Germany; 5. Cardio Metabolic Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 6. Medicine Unit of Endocrinology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden; 7. Cardio Metabolic Unit, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden展开收起
283
天
A Practical Framework for Understanding Cost-Effectiveness and Decision Risk in Health Benefits Package Design
作者
Cassandra Nemzoff; Sabine Grimm; Manuela Joore; Andres Madriz-Montero; Stella Matutina Umuhoza; James Humuza; Sedona Sweeney; Rob Baltussen; Anna Vassall展开收起
作者单位
1. Department of Global Health, London School of Hygiene and Tropical Medicine, London, UK; 2. Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre+, Maastricht, Netherlands; 3. Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands; 4. School of Public Health, University of Rwanda, Kigali, Rwanda; 5. Radboud University Medical Center, Nijmegen, Netherlands展开收起
151
天
Spillover Effects of Medical Innovations: A Universal and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time
作者
Rebecca Grün; Diego Hernandez; Adnan Atitallah; Platon Peristeris; Lena Steinbeck; Eva Levi,; Malina Müller展开收起
作者单位
1. Department of Health Economics, WifOR Institute, Darmstadt, Germany; 2. Department of Health Economics, WifOR Institute, Athens, Greece; 3. Die Senatorin für Gesundheit, Frauen und Verbraucherschutz Bremen, Bremen, Germany展开收起
172
天
Estimating the Share of Social Surplus Generated by Pharmaceutical Innovation Accruing to Manufacturers: A Systematic Literature Review
作者
Robert J. Nordyke; Tyler D. Wagner; Janine Ross; Sreeranjani Menon; Jonathan D. Campbell展开收起
作者单位
1. Beta6 Consulting, Topanga, United States; 2. National Pharmaceutical Council, Washington, USA; 3. Petauri Evidence, York, England; 4. Massachusetts College of Pharmacy and Health Sciences, Boston, USA展开收起
198
天
Evaluating Mongolia’s Sugar-Sweetened Beverage Tax: A Cost-Effectiveness Analysis
作者
Nyamdavaa Byambadorj; Rohan Best; Undram Mandakh; Kompal Sinha展开收起
作者单位
1. Department of Economics, Macquarie Business School, Macquarie University, Sydney, Australia; 2. Department of Family Medicine, School of Medicine, Mongolian National University of Medical Science, Ulaanbaatar, Mongolia展开收起
149
天
Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile
作者
Yuna Lim; Gerardo Chowell; Eunok Jung展开收起
作者单位
1. Department of Mathematics, Konkuk University, Seoul, Republic of Korea; 2. Department of Population Health Sciences, Georgia State University, Atlanta, USA; 3. Department of Applied Mathematics, Kyung Hee University, Yongin, Republic of Korea展开收起
FAQ
Applied Health Economics and Health Policy审稿要多久?
截至2026-11-18,CrushSCI 收录了 Applied Health Economics and Health Policy 的 20 篇完整审稿记录。最快一篇从收稿到录用用了 87 天(Cost Effectiveness of Endovascular Thrombectomy for Large Ischemic Strokes: A US Healthcare Payer Markov Model Informed by Randomized Trials,2026-01-03 收稿,2026-03-31 录用),最慢一篇用了 367 天;平均 193.3 天,中位数 175.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
